{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:32:44Z","timestamp":1790213564532,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.leukres.2017.10.010","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T16:32:55Z","timestamp":1509121975000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission"],"prefix":"10.1016","volume":"63","author":[{"given":"Anna","family":"Candoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Zannier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Fil\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Dubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Rabassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Toffoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie W.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.10.010_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbmt.2014.10.026","article-title":"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"21","author":"Vyas","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.leukres.2017.10.010_bib0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.24439","article-title":"Acute myeloid leukemia: 2016 Update on risk-stratification and management","volume":"91","author":"Estey","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","article-title":"Acute myeloid leukemia in adults","volume":"381","author":"Ferrara","year":"2013","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.leukres.2017.10.010_bib0020","first-page":"1","article-title":"Acute myeloid leukemia: a concise review","volume":"5","author":"Saulz","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.leukres.2017.10.010_bib0025","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2017.10.010_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11899-015-0260-7","article-title":"Minimal residual disease in acute myeloid leukemia-current status and future perspectives","volume":"10","author":"Kayser","year":"2015","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.leukres.2017.10.010_bib0035","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1200\/JCO.2014.58.3518","article-title":"Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia","volume":"33","author":"Chen","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/annonc\/mdt320","article-title":"Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"6","author":"Fey","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.beha.2014.10.008","article-title":"MRD in AML: it is time to change the definition of remission","volume":"27","author":"Ossenkoppele","year":"2014","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","article-title":"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-Based definition of complete remission","volume":"34","author":"Araki","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies: a review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.10.010_bib0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/blood-2011-08-363291","article-title":"Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia","volume":"119","author":"Buccisano","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.010_bib0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2017.10.010_bib0070","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V91.8.2969.2969_2969_2976","article-title":"Wilms\u2019 tumor gene (WT1) competes with differentiation-Inducing signal in hematopoietic progenitor cells","volume":"91","author":"Inoue","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.010_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000077562","article-title":"WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndromes","volume":"112","author":"Cilloni","year":"2004","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.2008.01158.x","article-title":"Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia","volume":"82","author":"Candoni","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1399-0012.2010.01251.x","article-title":"Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia","volume":"25","author":"Candoni","year":"2011","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.leukres.2017.10.010_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cam4.593","article-title":"Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients","volume":"5","author":"Malagola","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.leukres.2017.10.010_bib0095","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","article-title":"Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study","volume":"27","author":"Cilloni","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2017.10.010_bib0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00277-014-2295-6","article-title":"Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis","volume":"94","author":"Yi-Ning","year":"2015","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.leukres.2017.10.010_bib0105","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/sj.leu.2402675","article-title":"Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients","volume":"16","author":"Cilloni","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.10.010_bib0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PDM.0b013e318257ddb9","article-title":"Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia","volume":"21","author":"Andersson","year":"2012","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0115","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0120","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"1995","key":"10.1016\/j.leukres.2017.10.010_bib0125","first-page":"825","article-title":"Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.leukres.2017.10.010_bib0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.10.010_bib0135","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.10.010_bib0140","first-page":"1149","article-title":"Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm's tumor 1 levels","volume":"93","author":"Rossi","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0145","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2016.159343","article-title":"Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis","volume":"102","author":"Buckley","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.10.010_bib0150","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/leu.2013.111","article-title":"Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML","volume":"27","author":"Nomdedeu","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.10.010_bib0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12253-015-0002-0","article-title":"WT1 expression in adult acute myeloid leukemia: assessing its presence: magnitude and temporal changes as prognostic factors","volume":"22","author":"Ujj","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.leukres.2017.10.010_bib0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/asheducation-2014.1.222","article-title":"Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for prime time?","author":"Grimwade","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.leukres.2017.10.010_bib0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2141.2009.07770.x","article-title":"High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival","volume":"146","author":"Jacobsohn","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.10.010_bib0170","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2017.167254","article-title":"Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia","author":"Guolo","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.10.010_bib0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4149\/neo_2013_011","article-title":"Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia \u2013 a useful tool for early detection of minimal residual disease","volume":"60","author":"Polak","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.leukres.2017.10.010_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ctr.12046","article-title":"Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis","volume":"27","author":"Valkova","year":"2013","journal-title":"Clin. Transplant."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T13:44:36Z","timestamp":1603201476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617305635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"alternative-id":["S0145212617305635"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.10.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}